在土耳其心力衰竭患者的结果
Anıl Şahin1, Mehmet Birhan Yilmaz2, Ahmet Çelik3
1Department of Cardiology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkiye.
Turkish journal of medical sciences
|December 30, 2024
概括
土耳其心力衰竭 (HF) 存活率反映了全球的比率,女性的寿命超过男性. 准则导向疗法可能会提高生存率,尽管医疗保健使用率仍然很高.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 土耳其面临着早期慢性病诊断的日益增长的趋势,包括心力衰竭 (HF),尽管人口年轻.
- 了解HF生存动态对于有效的公共卫生战略至关重要.
研究的目的:
- 分析土耳其心力衰竭存活率.
- 调查指导方针导向治疗对HF结局的影响.
- 为了确定基于性别的差异HF管理和生存.
主要方法:
- 在全国范围内对2,701,099名成人心力衰竭患者进行了回顾性队列分析.
- 数据来源于土耳其卫生部的国家电子数据库.
- 多变量回归分析确定了死亡率预测因素,并检查了住院模式.
主要成果:
- 整体心力衰竭死亡率为33.7%,男性 (35.0%) 的死亡率高于女性 (32.5%).
- 患有较高的并发症负担,尿酸的增加和较低的淋巴膜过率的患者的死亡率增加.
- 在住院模式和住院时间方面,观察到明显的性别和年龄差异.
结论:
- 土耳其心力衰竭存活率与国际数据一致.
- 女性患者比男性患者的生存率更好.
- 广泛采用指导方针导向疗法与改善的生存率有关,以及高的医疗利用率,特别是在紧急情况下.
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: β-Blockers
257
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
257
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
299
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
Heart Failure Drugs: Diuretics
273
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
273
Increased pulse rate
620
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
620
Heart Failure Drugs: Inotropic Agents
395
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
395


